Skip to main content
HR 4710 116th Congress House Armed Forces and National Security Buy American requirements Congressional oversight Drug safety, medical device, and laboratory regulation Health technology, devices, supplies Immunology and vaccination Industrial policy and productivity Manufacturing Military medicine Military operations and strategy Military procurement, research, weapons development Military readiness Prescription drugs Public contracts and procurement Strategic materials and reserves Veterans' medical care

Pharmaceutical Independence Long-Term Readiness Reform Act

Introduced: May 5, 2020 Introduced by: Garamendi, John Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2019
Referred to the Subcommittee on Health.
Oct 17, 2019
Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 17, 2019
Sponsor introductory remarks on measure. (CR E1297-1298)
Oct 17, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Pharmaceutical Independence Long-Term Readiness Reform Act

This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.

What's happening now November 8, 2019

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 14
All 14 Democratic 3 Republican 7
R
Johnson, Dusty
South Dakota · May 19, 2020
Hagedorn, Jim
· May 12, 2020
 D
Case, Ed
Hawaii · May 8, 2020
 D
Cohen, Steve
Tennessee · May 8, 2020
 R
Smith, Christopher H.
New Jersey · May 8, 2020
 R
Stauber, Pete
Minnesota · May 5, 2020
Tipton, Scott
· May 5, 2020
 R
Bacon, Don
Nebraska · Apr 28, 2020
 R
Guest, Michael
Mississippi · Apr 28, 2020
 R
Stefanik, Elise M.
New York · Apr 17, 2020
 R
Fitzpatrick, Brian K.
Pennsylvania · Mar 2, 2020
Gianforte, Greg
· Feb 14, 2020
 D
Escobar, Veronica
Texas · Nov 8, 2019
Hartzler, Vicky
· Oct 17, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4710: Pharmaceutical Independence Long-Term Readiness Reform Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4710/
MLA
"H.R. 4710: Pharmaceutical Independence Long-Term Readiness Reform Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4710/.
Bluebook (legal)
H.R. 4710, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4710/.
Markdown link
[H.R. 4710: Pharmaceutical Independence Long-Term Readiness Reform Act](https://openamerica.io/bill/116-HR-4710/)
Report a problem